Main navigation

VM5: CVMP Guidelines Update:
Data protection (Article 40.5),
prescription status (Article.34) and benefit-risk

By 2022-12-05T00:01:00

Emily Drury

The secondary legislation and guidelines are as critical as Regulation 2019/6 itself in defining the future landscape for animal health in the EU. The concept and definitions of benefit-risk affect many different aspects of veterinary medicines regulation, as per the legislation.

 This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.

 

Not a TOPRA member yet? Join our global community.

Five great reasons to become a TOPRA member:

  1. Great savings on our events and training.
  2. Be part of our dynamic international community.
  3. Contribute to the profession.
  4. Grow your skills and knowledge.
  5. Take your career to the next level.

Become a member today!

Have you heard what you’re missing? Listen now to the RegRapPod podcast show, for free!